| Backer MV, Gaynutdinov TI, Gorshkova II, Crouch RJ, Hu T, Aloise R, Arab M, Przekop K, Backer JM
(2003)
J Controlled Release,
89,
499-511 |
| Drug Studies |
| None |
| Protein recombinantly expressed as and refolded from inclusion bodies. |
| Escherichia coli |
| BL21(DE3) |
| 37.0 |
| 2 |
| pET29a(+) |
| Cells were grown in Circle Grow medium (Q-Biogen), expression was induced with 1mM IPTG when OD600 reached 0.5-0.7. Cells were grown for a further 2h at 37degC then harvested by centrifugation (15min x 5000g). |
| IPTG |
| OD 600 =
0.5-0.7 |
| Sonication |
| None |
| None |
| insoluble |
| Dialysis |
| BugBuster (Novagen)/CelLytic B (Sigma), HisBind buffer (Novagen) |
| 20mM TrisHCl, 100mM NaCl, 8M Urea pH 8.0 |
| 1:20mM TrisHCl 2M Urea, 1mM glutathione, 0.4mM oxidized glutathione, 0.5M arginine, pH 8.0/2: 20mM TrisHCl pH 8.0 |
| None |
| no tag |
| 8.0 |
| 25.0 |
|
|
| GSH/GSSG |
| 1mM/0.4mM,1mM/0.4mM |
| The cells were lysed using BugBuster reagent (Novagen) according to the instructions of the manufacturer. The inclusion bodies were were centrifuged and washed with BugBuster reagent, followed by CelLytic B reagent (Sigma) diluted 1:10 with water, and then finally 1x HisBind buffer (Novagen). The inclusion bodies were solubilized by sonication in solubilization buffer. The protein was then refolded by a 2-step dialysis process, firstly for 20h against 20 volumes of refolding buffer 1, then for 24h against 100 volumes of refolding buffer 2.
|
| Enzyme activity |
| None |
| None,L-Arginine |
| 0.5M |
|
| >95% |
| Hu-VEGF - same protocol as for VEGF, see separate record no.1508
Other constructs also purified:
HuS (aa.18-125 or 18-127) - see separate protocols, records no.1507, 7k9h3
|